Ablynx - Company & Market Research Reports

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, oncology, and respiratory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.


Global Gout Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Gout Therapeutics Market 2016-2020

  • Report
  • 59 Pages
From
Psoriasis Treatments 2012-2013 Patent Landscape - Product Thumbnail Image

Psoriasis Treatments 2012-2013 Patent Landscape

  • Report
  • 82 Pages
From
 What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other]) - Product Thumbnail Image

What's Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

  • Report
  • 203 Pages
From
Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Rheumatoid - Inflammatory Diseases Markers Tests - Medical Devices Pipeline Assessment, 2017

  • Report
  • 161 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs

  • Report
  • 126 Pages
From
Global Rheumatoid Arthritis Drugs Market 2016-2020 - Product Thumbnail Image

Global Rheumatoid Arthritis Drugs Market 2016-2020

  • Report
  • 126 Pages
From
Systemic Lupus Erythematosus - Market Insight, Epidemiology and Market Forecast - 2027 - Product Thumbnail Image

Systemic Lupus Erythematosus - Market Insight, Epidemiology and Market Forecast - 2027

  • Drug Pipelines
  • 128 Pages
From
Systemic Lupus Erythematosus - Pipeline Review, H2 2017 - Product Thumbnail Image

Systemic Lupus Erythematosus - Pipeline Review, H2 2017

  • Report
  • 427 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Report
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Report
  • 1020 Pages
From
Nanoparticle Drug Delivery Market Report - Product Thumbnail Image

Nanoparticle Drug Delivery Market Report

  • Report
  • 301 Pages
Bispecific Antibodies: Clinical Trial Tracker - Product Thumbnail Image

Bispecific Antibodies: Clinical Trial Tracker

  • Clinical Trials
From
Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022 - Product Thumbnail Image

Global Double Barreled Antibodies Drug Sales (BLINCYTO & Removab), Pipeline Analysis (By Phase, Technology, and Indication), & Global Market Forecasts 2022

  • Report
  • 80 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 140 Pages
From
Nebulizers - Medical Devices Pipeline Assessment, 2018 - Product Thumbnail Image

Nebulizers - Medical Devices Pipeline Assessment, 2018

  • Report
  • 106 Pages
From
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update

  • Report
  • 462 Pages
From
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update - Product Thumbnail Image

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies - 2016 Update

  • Report
  • 124 Pages
From
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Report
  • 82 Pages
From
Global Nanomedicine Market Analysis & Trends - Industry Forecast to 2025 - Product Thumbnail Image

Global Nanomedicine Market Analysis & Trends - Industry Forecast to 2025

  • Report
  • 169 Pages
From
Loading Indicator
adroll